Caspase-3 activity in R28 cells increased significantly after treatment with 7kCh. Values for untreated cells and DMSO-treated cultures were 5988 ± 623 and 2575 ± 862, respectively
(Fig. 5A) . Cells treated with 7kCh alone showed mean fluorescence of 34,747 ± 4005, but values were 29,304 ± 3321, 30,493 ± 6621, and 30,333 ± 2060 for 7kch + LDL, 7kCh + z-VAD-fmk, and 7kCh + LDL + z-VAD-fmk, respectively. Although caspase-3 activation is a hallmark of apoptosis, we wanted to verify with the DNA fragmentation assay that the R28 cells were indeed undergoing apoptosis.
Figure 5Bshows that after treatment with 7kCh for 24 hours, the DNA laddering patterns seen on the 2% agarose gel electrophoresis had the distinct pattern of 200- to 500-bp fragmented DNA characteristics of apoptotic cells. In contrast, untreated R28 cells lacked this fragmented DNA pattern. In
Figure 5A , we were surprised that neither LDL nor z-VAD-fmk decreased caspase-3 activity significantly in R28 cultures. Therefore, to demonstrate that the z-VAD-fmk inhibitor was working effectively, human ARPE-19 cell cultures were established, and experiments were repeated
(Fig. 5C) . 7kCh-treated ARPE-19 cells had increased caspase-3 activity compared with DMSO-treated cultures (12,311 ± 998 vs. 6086 ± 1576). Caspase-3 activity decreased in the 7kCh + z-VAD-fmk cultures (5512 ± 243) compared with 7-kCh–treated cultures (
P < 0.001). In another experiment, 5 μM epicatechin significantly inhibited the 7kCh-induced caspase-3 activity in R28 cells
(Fig. 5D) . With the addition of epicatechin, mean fluorescence was reduced to 26,805 ± 1693 compared with mean fluorescence of 35,719 ± 6895 with 7kCh alone (
P < 0.05).